Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8)

Günter Emons*, Christian Kurzeder, Barbara Schmalfeldt, Petra Neuser, Nikolaus De Gregorio, Jacobus Pfisterer, Tjoung Won Park-Simon, Sven Mahner, Willibald Schröder, Hans Joachim Lück, Martin Leonhard Heubner, Lars Hanker, Falk Thiel, Felix Hilpert

*Corresponding author for this work
26 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8)'. Together they form a unique fingerprint.

Medicine & Life Sciences